SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
1-Year Return
40.04%
This Quarter Return
+13.07%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$174M
AUM Growth
+$60M
(+53%)
Cap. Flow
+$37.6M
Cap. Flow
% of AUM
21.63%
Top 10 Holdings %
Top 10 Hldgs %
68.58%
Holding
37
New
15
Increased
5
Reduced
10
Closed
7
Top Buys
| 1 |
Vanda Pharmaceuticals
VNDA
|
$19.1M |
| 2 |
Ligand Pharmaceuticals
LGND
|
$18.9M |
| 3 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$7M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$5.81M |
| 5 |
Aptevo Therapeutics
APVO
|
$3.51M |
Top Sells
Sector Composition
| 1 | Healthcare | 92.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
DiaMedica Therapeutics
DMAC
$317M
| $1.14M | 0.65% |
+250,000
| New | +$1.14M |
|
27
Xenon Pharmaceuticals
XENE
$3.02B
| $1M | 0.58% |
+98,860
| New | +$1M |
|
|
SBBP
28
DELISTED
Strongbridge Biopharma plc.
SBBP
| $932K | 0.54% |
+187,074
| New | +$932K |
|
29
Collegium Pharmaceutical
COLL
$1.21B
| $909K | 0.52% |
+60,045
| New | +$909K |
|
30
Alphatec Holdings
ATEC
$2.43B
| – | – |
-338,278
| Closed | -$775K |
|
31
Astria Therapeutics
ATXS
$424M
| – | – |
-6,948
| Closed | -$182K |
|
|
MTEM
32
DELISTED
Molecular Templates, Inc.
MTEM
| – | – |
-7,647
| Closed | -$463K |
|
|
BSTC
33
DELISTED
BioSpecifics Technologies Corp.
BSTC
| – | – |
-217,395
| Closed | -$13.2M |
|
|
CORV
34
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| – | – |
-424,101
| Closed | -$1.06M |
|
|
NVLN
35
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| – | – |
-531,662
| Closed | -$447K |
|
|
CEMI
36
DELISTED
Chembio diagnostics, Inc.
CEMI
| – | – |
-147,011
| Closed | -$832K |
|